RAD9A has a dual role in cancer (lack of the protein causes cellular sensitivity to DNA damage and in turn provokes cancer, the abundance of the protein due to hypermethylation in intron 2 of the gene leads to advance cancer conditions in prostate and breast cancer). Here, RAD9A is linked to breast cancer.